News summary
[National Health Commission and other departments: Steadily promote the price control of drugs linked to the Internet, and strive to correct unfair and discriminatory high prices] Securities Times News, the National Health Commission and other departments issued a 2024 revision of irregularities in the field of pharmaceutical purchase and sales and medical services. Key points of work on unhealthy trendsbaccaratnotinoNotice, itsbaccaratnotino...
Newsletter text
[National Health Commission and other departments: Steadily promote the price control of drugs linked to the Internet, and strive to correct unfair and discriminatory high prices] Securities Times News, the National Health Commission and other departments issued a notice on the key points of correcting unhealthy trends in the field of pharmaceutical purchase and sales and medical services in 2024, which points out that price governance should be improved and the reform of medical insurance payment methods should be continued. Steadily advance the price management of drugs linked to the Internet, focus on correcting unfair and discriminatory high prices, and continue to promote balanced and transparent prices linked to the Internet. Strengthen the verification and disposal of drug consumables with abnormal price fluctuations such as first price increases, extreme values, and large price differences, promote the use of drug quality, efficacy evaluation and other indicators as factors in drug procurement review, and implement a price solicitation credit evaluation system. Promote third-party departments to handle complaints during the drug recruitment process and increase supervision over drug recruitment and procurement. Continue to improve mechanisms such as the management and adjustment of core elements of medical insurance payment, opinion collection and feedback, group adjustment, negotiation and negotiation, implement dynamic adjustment of medical service prices on a regular basis, guide various localities to carry out price adjustment assessments for this year in accordance with regulations, and within the total amount control range based on the evaluation results, price adjustments will be carried out within both rises and falls. Proofread by: Wang Jincheng